SENSEX 77039.76 (0.16) |
Nifty 50 23849.75 (0.16) |
Nifty Bank 55664.3 (0.22) |
Nifty IT 31908.15 (-1.98)|
Nifty Midcap 100 59138.25 (0.92) |
Nifty Next 50 70306.55 (0.98) |
Nifty Pharma 27335.45 (0.43) |
Nifty Smallcap 100 18882.85 (1.23) |
Today’s Low
2042.55
Today’s High
2180.80
Open
2053.30
Perv Close
1982.55
52W Low
906.20
52W High
1235.65
WeekChge
16.06
MonthChge
11.86
YearChge
64.04
P/E Ratio (TTM)
45.44
P/BV
195.60
EPS
43.63
FV
10
MCAP
37,611.08
Dividend Yield (%)
0.18
Volumes soar at Emcure Pharmaceuticals Ltd counter
Emcure Pharmaceuticals Ltd consolidated sales up 9.30% on year in Q3FY2026, net profit expanded by 11.14%
Emcure Pharmaceuticals Ltd consolidated sales up 9.30% on year in Q3FY2026, net profit improved by 11.14%
Emcure Pharmaceuticals to review quarterly results at board meeting November 3, 2026
Emcure Pharmaceuticals received a certificate from MUFG Intime India regarding securities dematerialization
Emcure Pharmaceuticals proposes merger with Zuventus and Emcutix, pending regulatory approvals
OI
OI Chg
Avg Price
Contracts Traded
Turnover(Cr)